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Abstract
The aim of the present study was to examine whether a C-reactive protein (CRP) ﬁrst approach would improve the detection rate of
postoperative complications by CT.
CRP is a useful biomarker to identify major complications following surgery for colorectal cancer.
Patients with histologically conﬁrmed colorectal cancer, who underwent elective surgery between 2008 and 2015 at a single centre
were included. Exceeding the established CRP threshold of 150mg/L on postoperative day (POD) 4 was recorded. Results of CT
performed between postoperative days 4 and 14 were recorded.
Four hundred ninety-ﬁve patients were included. The majority were male (58%), over 65 (68%), with node-negative disease (66%)
and underwent open surgery (70%). Those patients who underwent a CT scan (n=93), versus those who did not (n=402), were
more likely to have a postoperative complication (84% vs 35%, P<0.001), infective complication (67% vs 21%, P<0.001), and
anastomotic leak (17% vs 2%, P<0.001). In patients who did not undergo a CT scan (n=402) exceeding the CRP threshold (n=117)
on POD 4 was associated with a higher rate of postoperative complication (50% vs 29%, P<0.001), infective complications (36% vs
15%, P<0.001), and anastomotic leak (4% vs 0.5%, P=0.009). In patients who did undergo a CT scan (n=93) exceeding the CRP
threshold (n=53) on POD 4 was associated with earlier CT (median POD 6 vs 8, P=0.001) but not postoperative complications.
A CRP ﬁrst approach resulted in earlier and improved detection of complications by CT following surgery for colorectal cancer.
Abbreviations: CRP = C-reactive protein, CT = computed tomography, FBC = full blood count, mGPS = modiﬁed Glasgow
Prognostic Score, POD = postoperative day.
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1. Introduction shown to be associated with increased local recurrence andColorectal malignancy is a leading cancer diagnosis in the
Western world.[1] Surgical resection is the mainstay of treatment
for colorectal cancer patients. However, surgery is associated
with considerable risk of postoperative complications including
anastomotic leak.[2]
Postoperative complications are associated with increased
short-term morbidity and mortality. Moreover, postoperative
complications, particularly infective complications, have beenEditor: Leonidas G. Koniaris.
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1diminished short- and long-term cancer-speciﬁc survival.[3–5]
Anastomotic leak and other signiﬁcant postoperative complica-
tions can present in a subtle manner and often only become
clinically evident relatively late in the postoperative course which
is likely to contribute to their impact on outcomes.[6]
It is now well understood that the magnitude of postoperative
systemic inﬂammatory response, measured by C-reactive protein
(CRP), is associatedwith postoperative complications.[7,8] Recent
consensus suggests that CRP concentrations exceeding 150mg/L
on postoperative days 3 or 4 should alert clinicians to possible
postoperative complications, including anastomotic leak.[9]
Furthermore it has been suggested that measuring the magnitude
of the postoperative systemic inﬂammatory response may be
useful in determining safe discharge, or indeed delaying it for
further investigation.[10]
Computed tomography (CT) is an important imaging
technique commonly used, with or without the addition of
rectal and/or oral contrast, to diagnose postoperative complica-
tions including anastomotic leak.[11,12] Studies have shown CT to
be both sensitive and speciﬁc in detection of these postoperative
complications.[13,14] However, in general, at present CT is used
sparingly and is usually carried out upon the surgical team’s
suspicion. As a consequence, CT is often not requested until late
in the postoperative course.[15]
Due to this strong association with the development of
postoperative complications, CRP may be a useful biomarker to
identify those patients who would beneﬁt from early CT.
[17]
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CRP ﬁrst approach would result in the earlier detection of
postoperative complications. The currently recruiting PRECious
trial aims to test this hypothesis prospectively by allocating
patients to standard care or to a postoperative care arm in which
patients will undergo contrast CT if they exceed a CRP threshold
of 140mg/L on postoperative day 3, 4, or 5.[16] The investigators
plan to use a stepped wedge design and will not blind clinicians in
the control arm to postoperative CRP concentrations. Given that
the current evidence for the association between CRP and
postoperative complications is robust this raises the possibility of
selection bias and crossover of patients allocated to the control
arm to early CT dependent on their CRP concentrations. Another
approach would be to audit surgical practice before the
introduction of a CRP ﬁrst postoperative protocol.
Therefore the aim of the present study, in a prospective cohort,
was to examine the relationship between the magnitude of the
postoperative systemic inﬂammatory response, postoperative
CT, and complications in patients who underwent surgery for
colorectal cancer.
2. Patients and methods
2.1. Patients
Patients with histologically conﬁrmed colorectal cancer, who
underwent elective surgery, with curative intent, between
February 2008 and April 2015 at a single centre were included
in the study. Patients who underwent emergency surgery,
palliative procedures, with metastatic disease, or who had
existing inﬂammatory conditions were excluded.
All patients received prophylactic antibiotics and venous
thromboprophylaxis before the induction of anesthesia as per
hospital policy. Patients had routine preoperative blood sampling
including a full blood count (FBC), serum CRP, and albumin
concentration.
On each postoperative day patients were clinically assessed and
had blood samples, including serum CRP, obtained routinely
until discharged. Further postoperative investigation and inter-
vention was at the discretion of the patient’s surgical team who
were not blinded to blood results. All CT scans performed in the
postoperative period were reported by a consultant radiologist at
the request of the referring surgical team. The use of rectal, oral,
and intravenous contrast was at the discretion of the supervising
radiologist. There was no CRP ﬁrst postoperative protocol in
place during the study period. This study was approved as part of
surgical audit by the West of Scotland Research Ethics
Committee.
2.2. Methods
Data were collected prospectively in a database, anonymized, and
subsequently analyzed. Recorded information included patient
demographics, clinicopathological, operative, and radiological
(CT) data. As CRP was being measured on postoperative day 4,
only CT scans performed between postoperative days 4 and 14
were included. Where multiple CT scans were performed during
this period, only the result of the ﬁrst scan in the postoperative
period was included.
Serum concentrations of CRP (mg/L) were measured using an
autoanalyzer (Architect; Abbot Diagnostics, Maidenhead, UK)
with a lower detectable limit of 0.2mg/L as was serum albumin
(normal range 35–50g/L). The preoperative modiﬁed Glasgow
Prognostic Score (mGPS) was calculated in patients for whom2serum CRP and albumin concentrations were available.
Breaching the established CRP threshold of 150mg/L on
postoperative day 4 was recorded.[9]
Infective complications were categorized as described previ-
ously.[6] Wound (superﬁcial surgical site) infection was deﬁned as
the presence of pus either spontaneously discharging from the
wound or requiring drainage. Deep surgical site infection was
deﬁned as surgical or image-guided drainage of intraabdominal
pus. Anastomotic leak was deﬁned as radiologically veriﬁed
ﬁstula to bowel anastomosis or diagnosed at laparotomy.
Pneumonia was deﬁned by fever above 38.5°C and consolidatory
chest X-ray ﬁndings requiring antibiotic treatment. Septicemia
was deﬁned by the presence of sepsis combined with positive
blood culture. Urinary tract infection was only included if
complicated by septicemia and conﬁrmed with positive urine
culture. Complications were also classiﬁed by severity using the
Clavien Dindo grade.[18]2.3. Statistical analysis
Categorical data were compared using the Chi-square test and
Chi-square for linear association where appropriate. Continuous
data were displayed as medians and ranges. These continuous
data were compared using the Mann–Whitney U test. Missing
data were excluded from analysis. Statistical analyses were
performed using IBM SPSS version 22 for Windows (Chicago,
IL). Two-tailed P values <0.05 were considered statistically
signiﬁcant.
3. Results
3.1. Patients
In total, 495 patients were included in the study (Fig. 1). The
majority were male (286, 58%), over 65 years old (335, 68%),
with node-negative disease (328, 66%) and underwent open
surgery (349, 70%) (Table 1). One hundred seventy (34%) of
patients exceeded the postoperative day 4 CRP threshold of 150
mg/L. Ninety-three (19%) patients underwent CT scan between
postoperative days 4 and 14 following surgery, of which the
majority received intravenous contrast (90, 97%) while 3 (3%)
patients received additional rectal contrast. The median duration
between surgery and CT scan was 7 days (range 4–14). Two
hundred eighteen patients (44%) developed a postoperative
complication of which 146 (29%) were infective and 51 (10%)
were Clavien Dindo grade 3 to 5. There were 22 anastomotic
leaks (4%).
When those patients who underwent surgery for colonic and
rectal cancers were compared, there was no signiﬁcant difference
in the proportion of patients exceeding the established
postoperative day 4 CRP threshold of 150mg/L (P=0.923),
undergoing a postoperative CT scan (P=0.239), having a
postoperative complication (P=0.052), anastomotic leak (P=
1.000), or the need for reoperation (P=0.402). Therefore, the 2
groups were subsequently analyzed together.
3.2. Association between postoperative CT, CRP, and
complications
In those patients who underwent a CT scan (n=93) compared
with those who did not (n=402, Fig. 1, Table 2) they were more
likely to have a postoperative complication of any kind (84% vs
35%, P<0.001), infective complication (67% vs 21%, P<
0.001), anastomotic leak (17% vs 2%, P<0.001), and have a
Elecve stage I-III resecons  Feb ’08 – Apr ’15
with POD 4 CRP measured
N=495
CT scan day 4-14 = 93 (19%)
Median days to CT =7
Any complicaon = 221 (43%)
Infecve comp = 147 (30%)
Leak = 22 (4%)
Intervenon = 40 (8%)
Median days to intervenon = 8
POD 4 CRP <150mg/L
N= 40
Median days to CT = 8
Any complicaon = 32 (80%)
Infecve comp = 24 (60%)
Leak = 4 (10%)
Intervenon = 8 (20%) 
Median days to intervenon = 13 
POD 4 CRP >150mg/L
N= 53
Median days to CT = 6 
Any complicaon = 46 (87%)
Infecve comp = 38 (72%)
Leak = 12 (23%)
Intervenon = 15  (28%)
Median days to intervenon = 8
All colorectal cancer resecons  Feb ’08 – Apr ‘15
N=742
Excluded:
Emergency surgery = 72
Mets/palliave = 19
CT before POD 4 = 28
Missing data on CT = 10
CRP not measured on POD 4 = 118
No CT
N= 402
Any complicaon = 140 (35%)
Infecve comp = 84 (21%)
Leak = 6 (2%)
Intervenon = 16 (4%)
Median days to intervenon = 6
CT POD 4-14
N= 93
Median days to CT = 7
Any complicaon = 78 (84%)
Infecve comp = 62 (67%)
Leak = 16 (17%) 
Intervenon = 23 (25%)
Median days to intervenon = 9
POD 4 CRP <150mg/L
N= 285
Any complicaon = 82 (29%)
Infecve comp = 42 (15%)
Leak = 1( 0.5%)
Intervenon = 8 (3%) 
Median days to intervenon = 4 
POD 4 CRP >150mg/L
N= 117
Any complicaon = 58 (50%)
Infecve comp = 42 (36%)
Leak = 5 (4%)
Intervenon = 8 (7%)
Median days to intervenon = 8  
Figure 1. Flowchart of postoperative outcomes stratiﬁed by postoperative day (POD) 4 C-reactive protein (CRP) and CT imaging following surgery for colorectal
cancer.
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signiﬁcantly more likely to require postoperative percutaneous
intervention or reoperation (25% vs 4%, P<0.001), although
there was no signiﬁcant association with time between initial
surgery and intervention.
In those patients who did not undergo a CT scan (n=402)
exceeding CRP concentration of 150mg/L (n=117) on postop-
erative day 4 (Fig. 1 and Table 3) was associated with a higher
rate of any kind of postoperative complication (50%vs 29%, P<
0.001), infective complications (36% vs 15%, P<0.001),3anastomotic leak (4% vs 0.5%, P=0.009), and higher Clavien
Dindo grade (P<0.001). There was a trend toward greater need
for postoperative intervention (7% vs 3%, P=0.089). Those
patients who required reoperation but did not undergo CT did so
for reasons including hemorrhage, wound dehiscence, stoma
complications, and discharge of enteric content from abdominal
wound.
In those patients who did undergo aCT scan (n=93) exceeding
a CRP concentration of 150mg/L (n=53) on postoperative
day 4 (Fig. 1 and Table 4) was not associated with any
Table 1
Clinicopathological and perioperative variables of patients under-
going elective surgery for colorectal cancer (N=495).
Characteristic All
N 495
Age (<65/65–74/>74) 160/195/137
Sex (male/female) 286/206
BMI (<20/20–25/26–30/>30) kg/m2 23/155/147/140
Smoking (never/ex/current) 209/197/75
ASA Grade (1/2/3/4) 96/222/153/20
Site (colon/rectum) 298/194
TNM stage (0/1/2/3) 13/105/207/167
Preoperative mGPS (0/1/2) 369/44/70
Neoadjuvant chemoradiotherapy (yes/no) 88/395
Operative approach (open/laparoscopic) 349/136
Stoma (yes/no) 172/319
Surgery >4h (yes/no) 153/295
POD 4 >150mg/L (yes/no) 170/322
CT scan during POD 4–14 (yes/no) 93/402
Time to CT scan (median, range, days) 7 (4–14)
Any postoperative complication (yes/no) 218/277
Anastomotic leak (yes/no) 22/473
Infective complication (yes/no) 146/349
Clavien Dindo grade (0/1–2/3–4/5) 277/167/47/4
Intervention (yes/no) 39/456
Time to intervention (median, range, days) 7 (0–29)
ASA=American Society of Anaesthesiology score, BMI=body mass index, CRP=C-reactive protein,
CT= computed tomography, mGPS=modiﬁed Glasgow Prognostic Score, POD=postoperative day.
McSorley et al. Medicine (2017) 96:7 Medicineclinicopathological variables, or postoperative complication
rates. There was a signiﬁcant association with earlier CT in
those patients who exceeded the established CRP threshold of
150mg/L on postoperative day 4 (median postoperative day 6 vs
8, P=0.001) and a trend toward earlier intervention (P=0.140).Table 2
Relationship between postoperative outcomes and CT between posto
stage I–III colorectal cancer (N=495).
Characteristic
No
N 402
Age (<65/65–74/>74) 130/153/116
Sex (male/female) 236/163
BMI (<20/20–25/26–30/>30) kg/m2 18/129/122/10
Smoking (never/ex/current) 171/158/62
ASA Grade (1/2/3/4) 77/179/124/18
Site (colon/rectum) 247/152
TNM stage (0/1/2/3) 10/87/168/134
Preoperative mGPS (0/1/2) 302/33/55
Neoadjuvant chemoradiotherapy (yes/no) 71/321
Operative approach (open/laparoscopic) 286/108
Stoma (yes/no) 131/267
Surgery >4h (yes/no) 111/247
POD 4 >150mg/L (yes/no) 117/282
Any postoperative complication (yes/no) 140/262
Infective complication (yes/no) 84/318
Anastomotic leak (yes/no) 6/396
Clavien Dindo grade (0/1–2/3–4/5) 262/118/21/1
Intervention (yes/no) 16/386
Time to intervention (median, range, days) 6 (0–28)
ASA=American Society of Anaesthesiology score, BMI=body mass index, CRP=C-reactive protein, C
43.3. CRP before CT, and the association with
complications and reoperation
In those patients who exceeded the postoperative day 4 CRP
threshold of 150mg/L (n=170) compared with those who did
not (n=325), were more likely to undergo a CT scan (30% vs
12%, P<0.001) and at an earlier time (median postoperative day
6 vs 8, P=0.001). They were more likely to have any kind of
postoperative complication (61% vs 36%, P<0.001), infective
complications (47% vs 21%, P<0.001), anastomotic leak (10%
vs 2%, P<0.001), and have a higher Clavien Dindo grade (P<
0.001). They were also more likely to require postoperative
percutaneous intervention or reoperation (14% vs 5%, P=
0.003). In those patients who exceeded the postoperative day 4
CRP threshold of 150mg/L (n=170), a subsequent CT scan (n=
53) compared to those without a CT scan was associated with a
higher rate of any kind of complication (87%vs 50%, P<0.001),
infective complications (72% vs 36%, P<0.001), anastomotic
leak (23% vs 4%, P=0.001), and a greater requirement for
postoperative percutaneous intervention or reoperation (28% vs
7%, P<0.001).
4. Discussion
The results of the present study show that the combination of a
CRP ﬁrst followed by CT approach appears to bring about the
earlier and improved detection of postoperative complications in
patients undergoing surgery for colorectal cancer.
In keeping with prior studies, the magnitude of the
postoperative systemic inﬂammatory response was associated
with complications and their severity.[8,19] Furthermore, it was of
interest that there was a signiﬁcant rate of clinically important
(i.e., Clavien Dindo grade ≥3) morbidity and mortality in those
patients who exceeded the CRP thresholds on postoperative day
4 but did not undergo CT scanning. This may represent a group
of patients who were “failed to rescue.”perative days 4 and 14 in patients undergoing elective surgery for
CT POD 4–14 P
Yes
93 —
30/42/21 0.490
50/43 0.353
5 5/26/25/35 0.157
38/39/13 0.867
19/43/29/2 0.527
51/42 0.239
3/18/39/33 0.755
67/11/15 0.376
17/74 0.881
63/28 0.520
41/52 0.053
42/48 0.006
53/40 <0.001
78/15 <0.001
62/31 <0.001
16/77 <0.001
15/49/26/3 <0.001
23/70 <0.001
9 (4–29) 0.117
T= computed tomography, mGPS=modiﬁed Glasgow Prognostic Score, POD=postoperative day.
[13]
Table 3
Relationship between postoperative outcomes and CRP on postoperative day 4 in patients undergoing elective surgery for colorectal
cancer who did not undergo CT between postoperative days 4 and 14 (N=402).
Characteristic POD 4 CRP >150mg/L P
No Yes
N 285 117 —
Age (<65/65–74/>74) 89/112/81 41/41/35 0.791
Sex (male/female) 159/123 77/40 0.093
BMI (<20/20–25/26–30/>30) kg/m2 14/88/97/66 4/41/25/39 0.339
Smoking (never/ex/current) 128/110/36 43/48/26 0.046
ASA Grade (1/2/3/4) 64/122/84/11 13/57/40/7 0.055
Site (colon/rectum) 175/107 72/45 1.000
TNM stage (0/1/2/3) 10/67/110/95 0/20/58/39 0.131
Preoperative mGPS (0/1/2) 226/21/27 76/12/28 <0.001
Neoadjuvant chemoradiotherapy (yes/no) 54/222 17/99 0.314
Operative approach (open/laparoscopic) 197/82 89/26 0.214
Stoma (yes/no) 90/191 41/76 0.561
Surgery >4h (yes/no) 85/175 26/72 0.306
Any postoperative complication (yes/no) 82/203 58/59 <0.001
Infective complication (yes/no) 42/243 42/75 <0.001
Anastomotic leak (yes/no) 1/284 5/112 0.009
Clavien Dindo grade (0/1–2/3–4/5) 203/69/13/0 59/49/8/1 <0.001
Intervention (yes/no) 8/277 8/109 0.089
Time to intervention (median, range, days) 4 (0–28) 8 (4–21) 0.145
ASA=American Society of Anaesthesiology score, BMI=body mass index, CRP=C-reactive protein, mGPS=modiﬁed Glasgow Prognostic Score, POD=postoperative day.
McSorley et al. Medicine (2017) 96:7 www.md-journal.comIn contrast to the widely used measurement of CRP on
postoperative day 4, postoperative CT scanning was only carried
out in approximately 1 in 5 patients. In those patients who
exceeded the CRP threshold on postoperative day 4, the use of
CT scan increased the detection rate of all complications,
infective complications, and anastomotic leak. In addition, the
combination of postoperative day 4 CRP and subsequent CT
scan was associated with a signiﬁcantly higher rate of
postoperative intervention.Table 4
Relationship between postoperative outcomes and CRP on postope
cancer who underwent CT between postoperative days 4 and 14 (N
Characteristic
No
N 40
Age (<65/65–74/>74) 11/19/10
Sex (male/female) 21/19
BMI (<20/20–25/26–30/>30) kg/m2 2/15/10/12
Smoking (never/ex/current) 15/15/9
ASA Grade (1/2/3/4) 9/18/12/1
Site (colon/rectum) 19/21
TNM stage (0/1/2/3) 2/6/19/13
Preoperative mGPS (0/1/2) 29/3/8
Neoadjuvant chemoradiotherapy (yes/no) 9/30
Operative approach (open/laparoscopic) 28/11
Stoma (yes/no) 19/21
Surgery >4h (yes/no) 16/24
Time to CT scan (median, range, days) 8 (4–12)
Any postoperative complication (yes/no) 32/8
Infective complication (yes/no) 24/16
Anastomotic leak (yes/no) 4/36
Clavien Dindo grade (0/1–2/3–4/5) 8/23/8/1
Intervention (yes/no) 8/40
Time to intervention (median, range, days) 13 (6–14)
ASA=American Society of Anaesthesiology score, BMI=body mass index, CRP=C-reactive protein, C
5A prior observational study by Straatman et al reported a
similar relationship betweenCRP andClavienDindo grade 3 to 5
complications, and a sensitivity and speciﬁcity of 92% and
100%, respectively, for contrast enhanced CT in the detection of
these major complications in abdominal surgery. Furthermore, a
recent observational study reported earlier diagnosis of postop-
erative complications, including by CT, and earlier intervention
following surgery for colorectal cancer after the adoption ofrative day 4 in patients undergoing elective surgery for colorectal
=93).
POD 4 CRP >150mg/L P
Yes
53 —
19/23/11 0.415
29/24 0.837
3/11/15/23 0.142
23/24/4 0.125
10/25/17/1 0.780
32/21 0.293
1/12/20/20 0.824
38/8/7 0.706
8/44 0.420
35/17 0.819
22/31 0.674
26/24 0.293
6 (4–14) 0.001
46/53 0.406
38/15 0.271
12/41 0.165
7/26/18/2 0.131
15/53 0.468
8 (4–29) 0.140
T= computed tomography, mGPS=modiﬁed Glasgow Prognostic Score, POD=postoperative day.
[20] [2] Buchs NC, Gervaz P, Secic M, et al. Incidence, consequences, and risk
McSorley et al. Medicine (2017) 96:7 Medicineroutine postoperative CRP measurement. However, the
accuracy of CT was not further stratiﬁed by CRP in either study.
In those patients who did not exceed the CRP threshold on
postoperative day 4, the use of CT scan also increased the
detection rate of complications and of anastomotic leak. Taken
together with the above results it is clear that patients who
underwent CT between postoperative days 4 and 14 and did not
exceed the CRP thresholds on postoperative day 4 did so for
reasons other than a raised CRP. Also, a small number of patients
required reoperation without having undergone postoperative
CT, primarily for complications which would not necessarily
require a CT in their diagnosis, for example, wound and stoma
complications, hemorrhage, and ﬁstulation.
Even serious complications, such as anastomotic leak and
those with a Clavien Dindo grade of 3 or more, are often not
diagnosed until late in the postoperative course, in some cases as
long as 12 days after surgery.[6,21] In keeping with this, half of all
CT scans were performed 7 days or more after surgery in the
present study. Current evidence suggests that CT imaging can
accurately diagnose signiﬁcant intraabdominal complications
much earlier in the postoperative period.[15] Indeed, the results of
the present study suggest that the use of a CRP ﬁrst approachmay
result in CT being performed earlier in the postoperative course.
However, further work is required to conﬁrm this observation.
The present study has several limitations. Due to the
observational nature of the study only a small number of
patients received rectal contrast, and a small number received no
contrast via any route due to renal failure, which may have
reduced the diagnostic accuracy of CT. In many cases in which
patients did not go on to reoperation the diagnosis of any
complication relied directly on the CT scan report, although the
use of Clavien Dindo grading has hopefully increased the
objectivity of complication recording. Furthermore, although the
present study investigated CRP thresholds on day 4, the median
time to CT imaging was 7 days. Therefore the results may not
reﬂect the accuracy of CT performed earlier in the postoperative
course.
The present study suggests that a CRP ﬁrst approach to the
diagnosis of major complications may result in earlier and
improved diagnosis of major postoperative complications by CT
imaging. This approach may result in improved postoperative
morbidity and mortality following surgery for colorectal cancer.Acknowledgment
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